- Home
- WYY vs ANTX Comparison
WYY vs ANTX Comparison
Compare WYY & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- ANTX
- Stock Information
- Founded
- WYY 1991
- ANTX 2017
- Country
- WYY United States
- ANTX United States
- Employees
- WYY N/A
- ANTX N/A
- Industry
- WYY EDP Services
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- ANTX Health Care
- Exchange
- WYY Nasdaq
- ANTX Nasdaq
- Market Cap
- WYY 33.6M
- ANTX 33.2M
- IPO Year
- WYY 1998
- ANTX 2022
- Fundamental
- Price
- WYY $3.13
- ANTX $1.09
- Analyst Decision
- WYY Strong Buy
- ANTX Buy
- Analyst Count
- WYY 1
- ANTX 2
- Target Price
- WYY $7.00
- ANTX $2.00
- AVG Volume (30 Days)
- WYY 67.4K
- ANTX 92.7K
- Earning Date
- WYY 08-13-2025
- ANTX 08-12-2025
- Dividend Yield
- WYY N/A
- ANTX N/A
- EPS Growth
- WYY N/A
- ANTX N/A
- EPS
- WYY N/A
- ANTX N/A
- Revenue
- WYY $142,582,209.00
- ANTX N/A
- Revenue This Year
- WYY $10.84
- ANTX N/A
- Revenue Next Year
- WYY $12.37
- ANTX N/A
- P/E Ratio
- WYY N/A
- ANTX N/A
- Revenue Growth
- WYY 24.03
- ANTX N/A
- 52 Week Low
- WYY $2.19
- ANTX $0.87
- 52 Week High
- WYY $6.25
- ANTX $2.98
- Technical
- Relative Strength Index (RSI)
- WYY 47.74
- ANTX 52.20
- Support Level
- WYY $3.05
- ANTX $1.05
- Resistance Level
- WYY $3.37
- ANTX $1.10
- Average True Range (ATR)
- WYY 0.16
- ANTX 0.03
- MACD
- WYY 0.01
- ANTX 0.01
- Stochastic Oscillator
- WYY 42.22
- ANTX 83.50
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.